Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

Patients are piling up in Minnesota emergency rooms once again, but it’s not just from COVID-19. State health officials say influenza is making a comeback, combining with COVID, norovirus and ...

The elderly man has been admitted to the hospital on Wednesday and his samples tested positive for HMPV on Thursday. The man ...

In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

Hospital leaders expect case volume of flu, the common cold, and respiratory syncytial virus, RSV, to keep climbing.

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...

The Centers for Disease Control and Prevention (CDC) is reporting a significant increase in respiratory illnesses nationwide, ...

And now, the human metapneumovirus, or HMPV for short, is infecting thousands of Americans around the country. The highly ...

State and federal data show high levels of respiratory illnesses. Here's what to know about the illnesses circulating this ...